The vma41-1 mutant was identified in a genetic screen designed to identify novel genes required for vacuolar H ؉ -ATPase activity in Saccharomyces cerevisiae. The VMA41 gene was cloned and shown to be allelic to the CYS4 gene. The CYS4 gene encodes the first enzyme in cysteine biosynthesis, and in addition to cysteine auxotrophy, cys4 mutants have much lower levels of intracellular glutathione than wild-type cells. cys4 mutants display the pH-dependent growth phenotypes characteristic of vma mutants and are unable to accumulate quinacrine in the vacuole, indicating loss of vacuolar acidification in vivo. The vacuolar proton-translocating ATPases (V-ATPase) is synthesized at normal levels and assembled at the vacuolar membrane in cys4 mutants, but its specific activity is reduced (47% of wild type) and the activity is unstable. Addition of reduced glutathione to the growth medium complements the pH-dependent growth phenotype, partially restores vacuolar acidification, and restores wild type levels of ATPase activity. Biochemical studies on the enzyme isolated from bovine clathrin-coated vesicles have indicated that reversible sulfhydryl-disulfide bond interconversion within the catalytic subunit may play a role in controlling V-ATPase activity in vivo (16 -18). Specifically, these studies show that disulfide bond formation between conserved cysteine residues near the nucleotide-binding site of the catalytic subunit results in inactivation of the V-ATPase and that this inactivation can be reversed by a disulfide interchange within the catalytic subunit. Furthermore, Dschida and Bowman (23) showed that reducing agents have a stabilizing effect on the V-ATPase from Neuro-* This work was supported in part by National Institutes of Health Grant R01-GM50322 and National Science Foundation Presidential Young Investigator Award MCB-9296244 (to P. M. K.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.‡ American Heart Association Established Investigator. To whom correspondence should be addressed: Dept. of Biochemistry and Molecular Biology, SUNY Health Science Center at Syracuse, 750 E. Adams St., Syracuse, NY 13210. Tel.: 315-464-8742; Fax: 315-464-8750; Email: kanepm@vax.cs.hscsyr.edu.1 The abbreviations used are: V-ATPase, vacuolar proton-translocating ATPase; V 1 , peripheral sector of the yeast vacuolar H ϩ -ATPase; V 0 , integral membrane sector of the yeast vacuolar H